HomeAI · summaries
Storia in 2 fonti
FDA advisors back approval of mRNA flu shot
An FDA advisory committee voted unanimously on June 18 to recommend that a messenger RNA-based influenza vaccine at the center of a recent change of heart by the FDA be approved for older adults.In two 9-0 votes, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) declared that the benefits of mRNA-1010 (mFlusiva, Moderna) outweigh the risks for adults aged 50
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
jpost.com
FDA approves Moderna's new mRNA-based flu vaccine | The Jerusalem Post
The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.
- ·
healio.com
FDA advisors back approval of mRNA flu shot
An FDA advisory committee voted unanimously on June 18 to recommend that a messenger RNA-based influenza vaccine at the center of a recent change of heart by the FDA be approved…